Aurangabad, India

Suresh Beri

This inventor holds 1 USPTO granted patent. Top assignee: Wockhardt Limited. Active years: 2006.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suresh Beri: Innovator in Peptide Chemistry

Introduction

Suresh Beri is a notable inventor based in Aurangabad, India. He has made significant contributions to the field of peptide chemistry, particularly in the production of somatostatin analogs. His work has implications for medical advancements and therapeutic applications.

Latest Patents

Suresh Beri holds a patent for the "Process for production of the somatostatin analog, octreotide." This invention relates to a method for the commercial production of octreotide using solution peptide chemistry and inexpensive amino acid derivatives. The process involves synthesizing the hexapeptide (Boc) D-Phe-Cys(Acm)-Phe-D-Trp-Lys(Boc)-Thr-OMe through the condensation of two tripeptide fragments. The linear octapeptide alcohol is then treated with iodine to yield the cyclic peptide octreotide.

Career Highlights

Suresh Beri is associated with Wockhardt Limited, a prominent pharmaceutical company. His innovative work in peptide synthesis has positioned him as a key figure in the development of therapeutic peptides. His patent demonstrates his expertise and commitment to advancing medical science.

Collaborations

Suresh Beri has collaborated with notable colleagues, including Nishith Chandra Chaturvedi and Ravindra Dattatraya Yeole. These collaborations have likely contributed to the success of his research and innovations.

Conclusion

Suresh Beri's contributions to peptide chemistry, particularly through his patent on octreotide production, highlight his role as an innovator in the pharmaceutical industry. His work continues to influence the field and offers potential benefits for medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…